ESR invests in biotech start-up

As part of the drive to remain at the forefront of technology, ESR has invested in AuramerBio Limited (ABL), a biotech start-up company out of Victoria University of Wellington that designs and develops aptamer biosensors.

An aptamer is a sequence of single-strand synthetic DNA that can bind to specific target molecules. They can be used to identify and quantify small molecules such as abused substances.

To read more, click here...

ESR| Posted on September 20, 2017

Link: Link to original article